About Us
Fresenius Kabi at a glance
Fresenius Kabi is a leading international health care company focusing on products for the therapy and care of critically and chronically ill patients inside and outside the hospital. We develop, produce and market pharmaceuticals and medical devices. Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi offers products for whole blood collection and processing as well as for transfusion medicine and cell therapies.
With our corporate philosophy of "caring for life", we are committed to supporting medical professionals in the best therapy of patients.
Fresenius Kabi employs around 30,000 people worldwide.
In 2012 the company reported sales of more than €4.5 billion.
Fresenius Kabi AG is a wholly owned subsidiary of the Fresenius SE & Co. KGaA health care group.
Key Figures
| € in millions |
2012 |
2011 |
Change |
| Sales |
4,539 |
3,964 |
15% |
| EBITDA |
1,101 |
955 |
15% |
| EBIT |
934 |
803 |
16% |
| Net Income* |
444 |
354 |
25% |
| Employees (Dec. 31) |
30,214 |
24,106 |
25% |
*Net income attributable to Fresenius Kabi AG.
